AMPLITUDE clinical research trial

Brief description of study

The AMPLITUDE clinical research trial will be looking at two different amounts (doses) of the investigational study drug, called VX-147, as treatment for APOL-1 related kidney disease. The study will help doctors and researchers decide which dose works the best. About 466 people will take part in this study around the world.

Clinical Study Identifier: s22-01371
Principal Investigator: David Michael Charytan.

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.